Devices › Tissue adhesive for the topical approximation of skin
Device brand name · Adhesive topical skin
Dermabond Advanced 0 7ml - 12ea: medical device reports filed with FDA
557 reports name it, 2019–2026. Manufacturer given most often on reports: Ethicon. Product code MPN.
- 557
- device reports naming the brand
- 0% of all MAUDE reports · about 80 a year
- 59
- reports, 12 months to August 2026
- 132 in the 12 months before
- 36.4%
- classified as malfunction
- 34.1% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
557 medical device reports received by FDA name the brand "Dermabond Advanced 0 7ml - 12ea" (adhesive topical skin); the manufacturer given most often on reports is Ethicon; received from July 2019 to June 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
59 reports arrived in the 12 months to August 2026, down 55% from 132 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (63.6%) and malfunction (36.4%); across all tissue adhesive for the topical approximation of skin reports (product code MPN) death is recorded in 0.2% and malfunction in 34.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are patient device interaction problem (16.7%), device contaminated during manufacture or shipping (11.3%) and break (5.6%). The patient problems coded most often are skin inflammation/ irritation, rash and erythema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 3,646 reports carrying product code MPN. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Patient device interaction problem | 93 | 16.7% | 4.4% |
| Device contaminated during manufacture or shipping | 63 | 11.3% | 2.2% |
| Breakthe device broke | 31 | 5.6% | 7.4% |
| Material integrity problema problem with the device material | 4 | 0.7% | 2.4% |
| Delivered as unsterile product | 3 | 0.5% | 0.3% |
| Device contamination with chemical or other material | 3 | 0.5% | 0.1% |
| Device markings/labelling problema problem with the device markings or label | 3 | 0.5% | 0.2% |
| Packaging problem | 3 | 0.5% | 0.7% |
| Activation problem | 2 | 0.4% | 0.1% |
| Contamination /decontamination problem | 1 | 0.2% | 0.1% |
| Loss of or failure to bond | 1 | 0.2% | 0.5% |
| Material discolored | 1 | 0.2% | 0.1% |
| Material separation | 1 | 0.2% | 0.2% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Skin inflammation/ irritation | 181 | 32.5% |
| Rashskin rash | 80 | 14.4% |
| Erythemaskin redness | 79 | 14.2% |
| Hypersensitivity/allergic reaction | 54 | 9.7% |
| Itching sensation | 50 | 9% |
| Blistera blister | 37 | 6.6% |
| Skin irritationirritated skin | 28 | 5% |
| Inflammationinflammation | 25 | 4.5% |
| Swelling/ edema | 24 | 4.3% |
| Tissue damage | 17 | 3.1% |
| Local reaction | 15 | 2.7% |
| Not applicable | 15 | 2.7% |
| Painpain, site not specified | 11 | 2% |
| Fluid discharge | 10 | 1.8% |
| Swellingswelling | 8 | 1.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Dermabond Advanced 0 7ml - 12ea | Product code MPN | All MAUDE reports |
|---|---|---|---|
| Reports | 557 | 3,646 | 26,136,888 |
| Share of that pool | — | 15.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 2 | 9 |
| Classified as injury | 63.6% | 54.9% | 36.2% |
| Classified as malfunction | 36.4% | 34.1% | 62.3% |
| Filed by the manufacturer | 100% | 94.5% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MPN
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Dermabond Topical Skin Adhesive | 476 | 0 | 0.4% |
| Dermabond Advanced Topical Skin Adhesive | 371 | 0 | 0% |
| Histoacryl Blue 0 5ml | 280 | 0 | 0% |
| Dermabond Unknown Product | 204 | 15 | 0.5% |
| DermaBond Advanced | 179 | 54 | 0% |
| Liquiband Exceed | 158 | 8 | 0% |
| Dermabond | 168 | 1 | 0% |
| Prineo Skin Closure System | 460 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Dermabond Advanced 0 7ml - 12ea reports
How many FDA reports name Dermabond Advanced 0 7ml - 12ea?
557 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 59 in the latest 12 months.
What kinds of events are reported?
injury (63.6%) and malfunction (36.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
patient device interaction problem (16.7%), device contaminated during manufacture or shipping (11.3%), break (5.6%), material integrity problem (0.7%) and delivered as unsterile product (0.5%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Dermabond Advanced 0 7ml - 12ea was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.